Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)

China flag China · Delayed Price · Currency is CNY
3.650
+0.030 (0.83%)
Feb 24, 2026, 3:04 PM CST
Market Cap10.88B -2.2%
Revenue (ttm)5.49B -2.4%
Net Income-66.13M
EPS-0.03
Shares Out3.00B
PE Ration/a
Forward PEn/a
Dividend0.03 (0.83%)
Ex-Dividend DateJun 24, 2025
Volume34,037,042
Average Volume54,677,416
Open3.650
Previous Close3.620
Day's Range3.620 - 3.660
52-Week Range3.080 - 4.490
Beta0.10
RSI45.62
Earnings DateApr 21, 2026

About SHE:300026

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 ... [Read more]

Sector Healthcare
Founded 1996
Employees 5,297
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300026
Full Company Profile

Financial Performance

In 2024, SHE:300026's revenue was 5.78 billion, a decrease of -5.34% compared to the previous year's 6.11 billion. Earnings were 21.47 million, a decrease of -95.76%.

Financial Statements